4 active not recruiting, 2 completed, 1 terminated. 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Active not recruiting 4, Completed 2, Terminated 1 |
Follow Oral Cavity Carcinoma: new trials by email Literature Review of Oral Cavity Carcinoma trials Research Report on Oral Cavity Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study Cisplatin, Intensity-Modulated Proton Therapy, Quality-of-Life Assessment - Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary | Phase 2 | Active not recruiting | Mayo Clinic | 174 | 2022-02-16 | 2026-07-16 |
| Customized 3D Printed Oral Stents During Head and Neck Radiotherapy Best Practice, Medical Device Usage and Evaluation - Head and Neck Carcinoma, Malignant Parotid Gland Neoplasm | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 88 | 2021-05-26 | 2026-10-06 |
| Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer Celecoxib, Placebo, Quality-of-Life Assessment - Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Terminated | University of Utah | 13 | 2019-11-27 | 2025-02-12 |
| Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia Laboratory Biomarker Analysis, Patient Observation, Pembrolizumab - Oral Cavity Carcinoma, Oral Intraepithelial Neoplasia | Phase 2 | Completed | M.D. Anderson Cancer Center | 15 | 2017-06-14 | 2025-10-23 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Biospecimen Collection, Computed Tomography, Echocardiography Test - Acinar Cell Carcinoma, Adenoid Cystic Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 798 | 2017-01-30 | 2026-06-17 |
| Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Laboratory Biomarker Analysis, Metformin Hydrochloride - Erythroplakia, Hyperplasia | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 26 | 2016-06-10 | 2026-06-26 |
| Physiotherapy Treatment for Patients Suffering From Head and Neck Cancer physiotherapy - Oral Cavity Carcinoma, Oropharyngeal Cancer | Phase 2 | Completed | Copenhagen University Hospital, Rigshospitalet | 97 | 2008-12-01 | 2013-07-02 |
Mouth Neoplasms (7) · Oropharyngeal Neoplasms (3) · Paranasal Sinus Neoplasms (3) · Hypopharyngeal Neoplasms (2) · Laryngeal Neoplasms (2) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Adenocarcinoma, Mucinous (1) · Adrenocortical Carcinoma (1) · Bile Duct Neoplasms (1) · Carcinoma (1) · Carcinoma, Acinar Cell (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Basal Cell (1) · Carcinoma, Endometrioid (1) · Carcinoma, Giant Cell (1)
Head and Neck Neoplasms (7) · Mouth Diseases (7) · Neoplasms (7) · Neoplasms by Site (7) · Stomatognathic Diseases (7) · Otorhinolaryngologic Diseases (5) · Otorhinolaryngologic Neoplasms (5) · Pharyngeal Diseases (5) · Pharyngeal Neoplasms (5) · Nose Diseases (4) · Nose Neoplasms (4) · Paranasal Sinus Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Respiratory Tract Diseases (4)
Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · CTLA-4 Antigen (1) · Celecoxib (1) · Cisplatin (1) · Ipilimumab (1) · Metformin (1) · Nivolumab (1) · Observation (1) · Physical Therapy Modalities (1) · Platinum (1) · Practice Guidelines as Topic (1) · Radiotherapy, Intensity-Modulated (1) · Standard of Care (1)
M.D. Anderson Cancer Center (2) · National Cancer Institute (NCI) (2) · Copenhagen University Hospital, Rigshospitalet (1) · Mayo Clinic (1) · University of Utah (1)
United States (6) · Canada (1) · Denmark (1) · Guam (1)
Anna Lee (1) · Renata Ferrarotto (1) · Richard Cannon, MD (1) · Sandip P Patel (1) · Scott C. Lester, M.D. (1) · Scott M Lippman (1)
PMID 25229260, PMID 31969335, PMID 33362722, PMID 33882143, PMID 34255745, PMID 34380663, PMID 34716198, PMID 38243705, PMID 38358334, PMID 39067873, PMID 39343510, PMID 39417692, PMID 39583952, PMID 39856213, PMID 40402690, PMID 40588371, PMID 41672597, PMID 41892875, PMID 41995270, PMID 42499790
N01CN00031 (1), P30CA023074 (1), P30CA042014 (1), U10CA180888 (1)